MMIP briefing paper: The fiscal benefits of establishing and retaining medicine manufacture in the UK
This paper highlights the factors which combine to make the UK one of the most competitive tax and fiscal frameworks globally for medicines manufacture and in the top tier of the G20. This is not widely recognised here in the UK or overseas and the purpose of this paper is to start to address this lack of awareness by setting out the UK proposition in a simple summary.
It’s been an energising week across the UK life sciences landscape, marked by major investment, important conversations and new opportunities for our community.
In this guest blog, Hareklea Markides, Innovation Lead - Medicines Manufacturing at Innovate UK, reflects on the UK BioIndustry Association's (BIA) annual #bioProcessUK conference.
In this blog, Abby Clark, Manufacturing Programme Manager at BIA, highlights some of the key achievements of BIA and ABPI’s Medicines Manufacturing Industry Partnership (MMIP).
A bumper update today as we highlight the critical importance of building UK capability and innovation leadership as geopolitics continues to provide uncertainty.
Fleet Bioprocessing Ltd has announced the launch of a new contract development service for Lateral Flow Devices (LFDs), expanding its capabilities in response to strong growth in point-of-care and decentralised diagnostics.
